Like us on Facebook?

It’s October.

And that means, it’s prime pink season. It’s national “Breast Cancer Awareness Month.”
 It’s that magical time of the year when shades of pale pink are plastered onto every product, every container, every conceivable gadget or gizmo that the Susan G. Komen Foundation can get their hands on.

But I am not buying it.

Susan G. Komen: For Cure or Con?

Susan G. Komen for the Cure is a multi-million-dollar company with assets totaling over $390 million dollars. Only 20.9% of these funds were reportedly used in the 2009-2010 fiscal year for research, “for the cure.” Where does the rest of the money go? Let’s have a look.
Additionally, the Susan G. Komen Foundation — the nonprofit organization that created the corporate phenomenon of pinkwashing — is hawking its own highly questionable pinkwashed product: a perfume called “Promise Me” that retails for $59.00 a bottle and reportedly contains chemicals, some of which are not listed on the label, that are a suspected hormone disruptor, a known neurotoxin and an anticoagulant banned for use in human food, respectively.

Research “for the Cure”

The first thing that pops into my mind when I think of a charity giant such as Komen funding research to prevent disease, is pouring money into Big Pharma’s pocketbook. After all, our only hope of a cure for cancer is that magical drug or vaccine that pharmaceutical corporations will one day rescue us all with, right?
Of course not.

But the reality that research in the conventional medical world is put toward, well, conventional medicine (allopathic drugs) remains. For me, this begs the question — where exactly does your research funding go, Komen?

SGK had the following to say regarding accusations that their organization funds pharmaceutical research:

“It’s been reported that Susan G. Komen for the Cure provides funding to pharmaceutical companies.  That is simply not true.  We have never funded pharmaceutical company research – our grants, totaling $450 million, have gone to research institutions in the U.S. and abroad.” – Susan G. Komen for the Cure
Ohh… okay. So you would never provide funding to pharmaceutical companies that sell disease-promoting, toxic chemical drugs to cancer patients.
But take their money? Sure!
“The Komen Foundation owns stock in General Electric, one of the largest makers of mammogram machines in the world. It also owns stock in several pharmaceutical companies, including AstraZeneca (now AzkoNobel).
AstraZeneca has long been a Komen booster, making educational grants to Komen and having a visible presence at the Race For the Cure. At the 1998 Food and Drug Administration hearings, the Komen Foundation was the only national breast cancer group to endorse the AstraZeneca cancer treatment drug tamoxifen as a prevention device for healthy but high-risk women, despite vehement opposition by most other breast cancer groups because of its links to uterine cancer.
The organization’s biggest sponsors are — surprise! — the corporations that profit from cancer through chemotherapy and radiation. To them, Komen for the Cure isn’t really about finding a cure for cancer; it’s about promoting cancer so that they can sell more drugs and radiotherapy that keeps more patients locked into a cycle of dependence on toxic cancer treatments.” -Well put, Natural News.
(Did you catch that bit about poisoning healthy women with the carcinogenic cancer drug, Tamoxifen, as a preventative measure? Yeah. Moving on…)

Susan G. Komen does indeed provide millions of dollars to fund research — but what exactly are they researching with those grants? One blogger diagnosed with metastatic breast cancer who had serious doubts of the intentions of the Komen foundation, dug through the research grants herself, and found the following information about how Komen’s research money is spent:

source



Make sure to Like Us on facebook to see more amazing stories like this